Digital StorytellingNCT07450742
Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning
A study testing HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING in people with Digital Storytelling, run by Kirsehir Ahi Evran Universitesi.
Trial summary
The aim of this study is to examine the effect of health education supported by digital storytelling on mothers' knowledge and attitudes towards newborn screening. It is a single-blind, controlled-group, randomized controlled experimental study. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Digital Storytelling
- What is being tested?
- HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 128 participants
- Where
- No sites listed yet
- Study dates
- 1 Mar 2026to 31 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Being 28-32 weeks pregnant
- Being able to speak and understand Turkish
- Using a smartphone with internet access
Who cannot join
- Not having previously given birth to a live child/Being a first-time mother
- Having a diagnosed or suspected congenital disease in the baby
- The pregnant woman having a vision or hearing problem
About this study
Official title: The Effect of Health Education Supported by Digital Storytelling on Maternal Knowledge and Attitudes Towards Newborn Screening
The aim of this study is to examine the effect of health education supported by digital storytelling on mothers' knowledge and attitudes towards newborn screening. It is a single-blind, controlled-group, randomized controlled experimental study. The hypotheses of the study are:
H0: Health education supported by digital storytelling has no effect on mothers' knowledge and attitudes towards newborn screening.
H1: Health education supported by digital storytelling has an effect on mothers' knowledge and attitudes towards newborn screening. Participants will:
- Be 28-32 weeks pregnant
- Be able to speak and understand Turkish
- Use a smartphone with internet access
Read the detailed description
The study will first obtain a list of pregnant women registered with each family physician at the family health centers in city center. This list will include the pregnant women's names, surnames, ages, and contact information. The pregnant women forming the research group will be contacted using the phone numbers obtained from the family health centers. After explaining the subject and importance of the study, they will be asked if they are willing to participate. The list forming the research group will be updated to include only those who volunteer for the study. Then, as a pre-test, an introductory information form and the Maternal Knowledge and Attitudes Towards Newborn Screening Scale will be administered to the individuals in the research group. After the pre-test is completed, the pregnant women in the research group will be assigned to experimental and control groups using stratified randomization according to their age. For this purpose, the pregnant women will be divided into two strata: those aged 18-35 and those over 35. After stratification, four blocks of eight people each were created, forming two separate groups, using the website randomizer.org.
Blinding In the study, the randomization process will be performed by someone other than a member of the research team, ensuring blinding. The experimental and control groups will be coded as A and B, ensuring statistical blinding as the statistician analyzing the data will not know whether the pregnant women are in the experimental or control group. Furthermore, participants will not be informed whether they are in the experimental or control group, ensuring participant blinding. Since the intervention will be performed by the researcher, researcher blinding was not possible. Thus, assignment bias, statistical bias, and reporting bias were prevented.
Outcomes Measures The outcome criterion in the study is the level of knowledge and attitude towards newborn screening. The measurement tool aimed at measuring this criterion is the Maternal Knowledge and Attitude Scale Towards Newborn Screening. The pre-test will be administered through self-report at the family health centers where the interviews with pregnant women are conducted, and the post-test will be administered through face-to-face interviews after the completion of a four-week health education program supported by digital storytelling. Intervention to be Applied to the Control Group: Two interviews will be conducted with the pregnant women in the control group at family health centers, four weeks apart. The pre-test will be administered in the first interview, and the post-test in the last interview. Telephone calls will be made to participants between the first and last weeks for reminder purposes.
Data Analysis The findings of the study will be analyzed in a computer environment. Intention to Treat (ITT) analysis will be performed to complete the missing data in the final test. Paired-sample t-test and independent samples t-test will be used for continuous data showing normal distribution. McNemar test for two dependent groups and chi-square test for two independent groups will be applied to categorical variables.
- Conditions
- Digital Storytelling
- Being tested
- HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLINGBehavioural
The health education program, supported by digital storytelling, to be applied to the experimental group is a four-week program. Sessions will be held face-to-face at family health centers one week apart. Telephone calls will be made during the first week to remind participants or inform them about their appointments. Four stories were created for the digital storytelling-supported health education program for the experimental group, using the website www.storyjumper.com. The first story covers the purpose and scope of newborn screenings, the second the testing process and possible outcomes, the third the definition of diseases and treatment options, and the fourth the parents' right to information and responsibility to participate in screenings.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | Participants in this arm will receive the structured health education supported by digital storytelling program consisting of 4 sessions delivered over 4 weeks. The program includes health education, face-to-face interview and digital storytelling related to newborn screening. Sessions will be conducted by trained personnel according to a standardized protocol. Receives: Behavioral: HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING |
| Control Group | No intervention | Participants in this arm will not receive the intervention program. They will continue with usual activities and/or standard care during the study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maternal Knowledge and Attitude Scale Towards Newborn Screening
The outcome criterion in this study is the level of knowledge and attitudes towards newborn screening. The measurement tool aimed at measuring this criterion is the Maternal Knowledge and Attitude Scale Towards Newborn Screening. The pre-test will be administered through self-report at family health centers where interviews are conducted with pregnant women, and the post-test will be administered through face-to-face interviews after the completion of a four-week health education program supported by digital storytelling.
Measured: Four weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2026
- Study start1 Mar 2026 (estimated)
- Primary completion30 Jun 2026 (estimated)
- Study completion31 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Digital StorytellingStudies of the same condition, open and under way.
- More trials run by Kirsehir Ahi Evran UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Care provider, Investigator
- Enrolment
- 128 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gizem Deniz Büyüksoy, Kirsehir Ahi Evran Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07450742
- Sponsor's protocol ID
- 2025-18/240
- Status last verified
- Mar 2026
- First submitted
- 24 Feb 2026
- Last updated
- 5 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Health Education Supported by Digital Storytelling on Maternal Knowledge and Attitudes Towards Newborn Screening
- ClinicalTrials.gov ID
- NCT07450742
- Acronym / sponsor ID
- 2025-18/240
- Conditions
- Digital Storytelling
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 128 participants (estimated)
- Lead sponsor
- Kirsehir Ahi Evran UniversitesiUniversity, hospital or other
- Study start
- 1 Mar 2026 (estimated)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 31 Aug 2026 (estimated)
- First posted
- 5 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to examine the effect of health education supported by digital storytelling on mothers' knowledge and attitudes towards newborn screening. It is a single-blind, controlled-group, randomized controlled experimental study. The hypotheses of the study are:
H0: Health education supported by digital storytelling has no effect on mothers' knowledge and attitudes towards newborn screening.
H1: Health education supported by digital storytelling has an effect on mothers' knowledge and attitudes towards newborn screening. Participants will:
- Be 28-32 weeks pregnant
- Be able to speak and understand Turkish
- Use a smartphone with internet access
Detailed description
The study will first obtain a list of pregnant women registered with each family physician at the family health centers in city center. This list will include the pregnant women's names, surnames, ages, and contact information. The pregnant women forming the research group will be contacted using the phone numbers obtained from the family health centers. After explaining the subject and importance of the study, they will be asked if they are willing to participate. The list forming the research group will be updated to include only those who volunteer for the study. Then, as a pre-test, an introductory information form and the Maternal Knowledge and Attitudes Towards Newborn Screening Scale will be administered to the individuals in the research group. After the pre-test is completed, the pregnant women in the research group will be assigned to experimental and control groups using stratified randomization according to their age. For this purpose, the pregnant women will be divided into two strata: those aged 18-35 and those over 35. After stratification, four blocks of eight people each were created, forming two separate groups, using the website randomizer.org.
Blinding In the study, the randomization process will be performed by someone other than a member of the research team, ensuring blinding. The experimental and control groups will be coded as A and B, ensuring statistical blinding as the statistician analyzing the data will not know whether the pregnant women are in the experimental or control group. Furthermore, participants will not be informed whether they are in the experimental or control group, ensuring participant blinding. Since the intervention will be performed by the researcher, researcher blinding was not possible. Thus, assignment bias, statistical bias, and reporting bias were prevented.
Outcomes Measures The outcome criterion in the study is the level of knowledge and attitude towards newborn screening. The measurement tool aimed at measuring this criterion is the Maternal Knowledge and Attitude Scale Towards Newborn Screening. The pre-test will be administered through self-report at the family health centers where the interviews with pregnant women are conducted, and the post-test will be administered through face-to-face interviews after the completion of a four-week health education program supported by digital storytelling. Intervention to be Applied to the Control Group: Two interviews will be conducted with the pregnant women in the control group at family health centers, four weeks apart. The pre-test will be administered in the first interview, and the post-test in the last interview. Telephone calls will be made to participants between the first and last weeks for reminder purposes.
Data Analysis The findings of the study will be analyzed in a computer environment. Intention to Treat (ITT) analysis will be performed to complete the missing data in the final test. Paired-sample t-test and independent samples t-test will be used for continuous data showing normal distribution. McNemar test for two dependent groups and chi-square test for two independent groups will be applied to categorical variables.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Behavioral: HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLINGParticipants in this arm will receive the structured health education supported by digital storytelling program consisting of 4 sessions delivered over 4 weeks. The program includes health education, face-to-face interview and digital storytelling related to newborn screening. Sessions will be conducted by trained personnel according to a standardized protocol. |
| Control Group | No intervention | –Participants in this arm will not receive the intervention program. They will continue with usual activities and/or standard care during the study period. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Being 28-32 weeks pregnant
- Being able to speak and understand Turkish
- Using a smartphone with internet access
Key exclusion criteria (3 listed)
- Not having previously given birth to a live child/Being a first-time mother
- Having a diagnosed or suspected congenital disease in the baby
- The pregnant woman having a vision or hearing problem
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLINGThe health education program, supported by digital storytelling, to be applied to the experimental group is a four-week program. Sessions will be held face-to-face at family health centers one week apart. Telephone calls will be made during the first week to remind participants or inform them about their appointments. Four stories were created for the digital storytelling-supported health education program for the experimental group, using the website www.storyjumper.com. The first story covers the purpose and scope of newborn screenings, the second the testing process and possible outcomes, the third the definition of diseases and treatment options, and the fourth the parents' right to information and responsibility to participate in screenings. | Behavioural | Intervention Group |
Primary outcome
Maternal Knowledge and Attitude Scale Towards Newborn Screening
Time frame: Four weeks
The outcome criterion in this study is the level of knowledge and attitudes towards newborn screening. The measurement tool aimed at measuring this criterion is the Maternal Knowledge and Attitude Scale Towards Newborn Screening. The pre-test will be administered through self-report at family health centers where interviews are conducted with pregnant women, and the post-test will be administered through face-to-face interviews after the completion of a four-week health education program supported by digital storytelling.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Mar 2026.
Related trials for Digital Storytelling
Recruiting
Digital Storytelling-Based Psychoeducation for Loneliness and Self-Efficacy in Adults Aged 65-74
Loneliness, Self-Efficacy
Recruiting
Virtual Reality-Enabled Digital Storytelling
Primiparous Pregnant Women
Not yet recruiting
Heart Voice: Starry Journey - A Digital ACT Intervention for ASD Caregivers
Autism Spectrum Disorder
Recruiting
Empowering Vietnamese Americans
HPV Vaccination, Cancer Prevention
Recruiting
Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations
Institutionalization, Elderly
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING in people with Digital Storytelling, run by Kirsehir Ahi Evran Universitesi.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maternal Knowledge and Attitude Scale Towards Newborn Screening (time frame: Four weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.